NDC 13985-805 - CMPK
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13985-805
- Package NDCs from labels
- 13985-805-50
- Manufacturer
- MWI (VetOne)
- Effective date
- 2026-03-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CMPK - MWI (VetOne) | MWI (VetOne) | 2026-03-20 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13985-805-50 | CMPK | 500 mL in 1 BOTTLE, PLASTIC | INJECTION, SOLUTION | 500 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Calcium Gluconate Monohydrate | ACTIVE INGREDIENT | CZN0MI5R31 | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Dextrose Monohydrate | ACTIVE INGREDIENT | LX22YL083G | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Magnesium Gluconate | ACTIVE INGREDIENT | T42NAD2KHC | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Potassium Chloride | ACTIVE INGREDIENT | 660YQ98I10 | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Sodium Hypophosphite Monohydrate | ACTIVE INGREDIENT | 4VN69WUP7N | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Calcium Cation | ACTIVE MOIETY | 2M83C4R6ZB | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Dextrose | ACTIVE MOIETY | IY9XDZ35W2 | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Magnesium cation | ACTIVE MOIETY | T6V3LHY838 | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Phosphorus | ACTIVE MOIETY | 27YLU75U4W | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Potassium cation | ACTIVE MOIETY | 295O53K152 | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride in Lactated Ringers and Dextrose | POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE, AND DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | dbed53b7-0109-4561-8342-0178ec8c64b0 | 2024-05-22 | Warnings, Adverse reactions | 660YQ98I10 LX22YL083G |
| Lactated Ringers and Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | 1b912c7e-f005-4af4-b683-083440964249 | 2024-05-22 | Warnings, Adverse reactions | 660YQ98I10 LX22YL083G |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | XLCare Pharmaceuticals, Inc. | 7fd82f08-8ad0-4ee2-8eb6-5c973f98baee | 2024-05-21 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Bryant Ranch Prepack | 7a220e87-ff72-417b-bc45-90a37b7f2aa6 | 2024-05-21 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Camber Pharmaceuticals, Inc. | b1e827aa-b2fb-4fa5-984d-ddd94338ff53 | 2024-05-14 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | 55d9ae37-4553-47e7-a2e3-86b48b5227cd | 2024-05-08 | Warnings, Adverse reactions | 660YQ98I10 LX22YL083G |
| Potassium Chloride in Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE | Fresenius Kabi USA, LLC | f0cc6713-4d47-49be-8116-901c99002b6b | 2024-05-07 | Warnings, Adverse reactions | 660YQ98I10 LX22YL083G |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | Asclemed USA, Inc. | f4ca52c6-9f90-7bb5-e053-2a95a90ae3ff | 2024-05-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride in Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE | Fresenius Kabi USA, LLC | 97001218-086c-430a-9e0d-6c7031c91d94 | 2024-05-06 | Warnings, Adverse reactions | 660YQ98I10 LX22YL083G |
| Calcium Gluconate | CALCIUM GLUCONATE | Fresenius Kabi USA, LLC | 7f5101e0-abf9-4fcf-8986-c799e3333434 | 2024-05-06 | Warnings, Adverse reactions | CZN0MI5R31 |
| Potassium Chloride in Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE | Fresenius Kabi USA, LLC | fe5b5182-c859-4c74-b2e0-467be5b2e329 | 2024-05-06 | Warnings, Adverse reactions | 660YQ98I10 LX22YL083G |
| Potassium Chloride in Sodium Chloride | SODIUM CHLORIDE AND POTASSIUM CHLORIDE | Fresenius Kabi USA, LLC | c2467d57-cd2d-4409-bcc0-50128bd01bba | 2024-04-30 | Warnings, Adverse reactions | 660YQ98I10 |
| LACTATED RINGERS | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Fresenius Kabi USA, LLC | 7a723a23-3bc1-4f69-b82f-d06a35dc68d6 | 2024-04-24 | Warnings, Adverse reactions | 660YQ98I10 |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | f2379398-a07b-417e-a022-f7b41f962067 | 2024-04-24 | Warnings, Adverse reactions | LX22YL083G |
| CALCIUM GLUCONATE | CALCIUM GLUCONATE | Amneal Pharmaceuticals Private Limited | 8ee79b4c-21d3-4742-ae37-e2f562917706 | 2024-04-18 | Warnings, Adverse reactions | CZN0MI5R31 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Bryant Ranch Prepack | 65e30d1a-50e9-4b84-ad4d-daaea91eab4b | 2024-04-09 | Warnings, Adverse reactions | 660YQ98I10 |
| Oral Health | ANTIMONIUM CRUDUM, ARSENICUM ALBUM, BISMUTHUM SUBNITRICUM, BORAX, BRYONIA (ALBA), CALCAREA PHOSPHORICA, CANDIDA ALBICANS, CHAMOMILLA, CINCHONA OFFICINALIS, DISCUS INTERVERTEBRALIS SUIS, STREPTOCOCCUS DYSGALACTIAE DNA, STREPTOCOCCUS MUTANS DNA, STREPTOCOCCUS PNEUMONIAE DNA, ECHINACEA PURPUREA, IGNATIA AMARA, JUGLANS CINEREA, KALI MURIATICUM, MAGNESIA MURIATICA, MERCURIUS SOLUBILIS, MURIATICUM ACIDUM, NUX MOSCHATA, ORAL MUCOSA (SUIS), OXYGENIUM, SAMBUCUS NIGRA, SEPIA, STAPHYLOCOCCUS AUREUS, | Deseret Biologicals, Inc. | 6f66ff40-6e0e-4a35-963c-965c65df76eb | 2024-04-01 | Warnings | 660YQ98I10 |
| Potassium Chloride in Dextrose and Sodium Chloride | DEXTROSE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE | B. Braun Medical Inc. | 59ccc717-c374-41c0-be58-9647df881160 | 2024-03-26 | Warnings, Adverse reactions | 660YQ98I10 |
| POKONZA | POTASSIUM CHLORIDE | Carwin Pharmaceutical Associates, LLC | 7c5cc705-e5da-4487-86c9-9d545a95afb4 | 2024-03-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Bio Cytotox Phase | PODOPHYLLUM PELTATUM, ASCORBICUM ACIDUM, GALIUM APARINE, HYDRASTIS CANADENSIS, NICOTINAMIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SARCOLACTICUM ACIDUM, THIAMINUM HYDROCHLORICUM, ALPHA-LIPOICUM ACIDUM, COLCHICUM AUTUMNALE, CONIUM MACULATUM, NATRUM OXALACETICUM, SULPHUR, VACCINIUM MYRTILLUS, NOREPINEPHRINE, ACETYLSALICYLICUM ACIDUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ANTHRACHINONUM, HISTAMINUM HYDROCHLORICUM, MAGNESIUM GLUCONICUM DIHYDRICUM, NADIDUM, NAPHTHOCHINONUM, PANTOTHENIC ACID, UBIDECARENONUM, | Deseret Biologicals, Inc. | ca632470-6cbc-4994-a7f0-95b6ad9aa44f | 2024-03-14 | Warnings | T42NAD2KHC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.